Citigroup Maintains Buy on Natera, Raises Price Target to $480
10/6/2026
Impact: 75
Healthcare
Citigroup analyst Albert Hu has maintained a 'Buy' rating on Natera (NASDAQ: NTRA) and increased the price target from $365 to $480. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: